During the past decade, Kidney Care & Transplant Services of New England conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kidney Care & Transplant Services of New England" #1 sponsor was "Amicus Therapeutics" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Complexa, Inc." with 1 trials sponsored and "HI-Bio" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kidney Care & Transplant Services of New England" #1 collaborator was "Arkana Labs" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Kidney Research Network, formerly NephCure Accelerating Cures Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kidney Care & Transplant Services of New England" are "Arteriovenous Fistula" (1 trials), "Chronic Kidney Disease" (1 trials), "End Stage Renal Disease" (1 trials), "Fabry Disease" (1 trials) and "Glomerulonephritis, Membranous" (1 trials). Many other conditions were trialed in "Kidney Care & Transplant Services of New England" in a lesser frequency.

Most popular intervention types in "Kidney Care & Transplant Services of New England" are "Drug" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arteriovenous fistula (AVF)" (1 trials), "CXA-10" (1 trials), "Covera Vascular Covered Stent" (1 trials), "Empagliflozin" (1 trials) and "Human Acellular Vessel (HAV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kidney Care & Transplant Services of New England" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Kidney Care & Transplant Services of New England". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Kidney Care & Transplant Services of New England, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kidney Care & Transplant Services of New England, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".